In the nucleus, NFATC1 transcriptionally upregulates osteoclast-specific gene ACP5 to promote the migration and invasion of CRC (Fig. 8), indicating that RANK might serve as a potential therapeutic target. Here, NFATC1 is linked to colorectal carcinoma.